Regulation of heparan sulfate 6-O-sulfation by beta-secretase activity.
The enzymes involved in glycosaminoglycan chain biosynthesis are mostly Golgi resident proteins, but some are secreted extracellularly. For example, the activities of heparan sulfate 6-O-sulfotransferase (HS6ST) and heparan sulfate 3-O-sulfotransferase are detected in the serum as well in the medium of cell lines. However, the biological significance of this is largely unknown. Here we have investigated by means of monitoring green fluorescent protein (GFP) fluorescence how C-terminally GFP-tagged HS6STs that are stably expressed in CHO-K1 cell lines are secreted/shed. Brefeldin A and monensin treatments revealed that the N-terminal hydrophobic domain of HS6ST3 is processed in the endoplasmic reticulum or cis/medial Golgi. Treatment of HS6ST3-GFP-expressing cells with various protease inhibitors revealed that the cell-permeable beta-secretase inhibitor N-benzyloxycarbonyl-Val-Leu-leucinal (Z-VLL-CHO) specifically inhibits HS6ST secretion, although this effect was specific for HS6ST3 but not for HS6ST1 and HS6ST2. However, Z-VLL-CHO treatment did not increase the molecular size of the HS6ST3-GFP that accumulated in the cell. Z-VLL-CHO treatment also induced the intracellular accumulation of SP-HS6ST3(-TMD)-GFP, a modified secretory form of HS6ST3 that has the preprotrypsin leader sequence as its N-terminal hydrophobic domain. Diminishment of beta-secretase activity by coexpressing the amyloid precursor protein of a Swedish mutant, a potent beta-secretase substrate, also induced intracellular HS6ST3-GFP accumulation. Moreover, Z-VLL-CHO treatment increased the 6-O-sulfate (6S) levels of HS, especially in the disaccharide unit of hexuronic acid-GlcNS(6S). Thus, the HS6ST3 enzyme in the Golgi apparatus and therefore the 6-O sulfation of heparan sulfates in the cell are at least partly regulated by beta-secretase via an indirect mechanism.
Nagai
Naoko
N
Institute for Molecular Science of Medicine, Aichi Medical University, Yazako, Nagakute, Aichi 480-1195, Japan.
Habuchi
Hiroko
H
Kitazume
Shinobu
S
Toyoda
Hidenao
H
Hashimoto
Yasuhiro
Y
Kimata
Koji
K
D053829:Amyloid Precursor Protein Secretases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D020126:Brefeldin A / Q000494:pharmacology; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D006056:Golgi Apparatus / Q000201:enzymology* / Q000235:genetics; D006497:Heparan Sulfate / Q000378:metabolism*; D006603:Hexuronic Acids / Q000378:metabolism; D006801:Humans; D007476:Ionophores / Q000494:pharmacology; D051379:Mice; D008985:Monensin / Q000494:pharmacology; D009842:Oligopeptides / Q000494:pharmacology; D021382:Protein Sorting Signals / Q000235:genetics; D017434:Protein Structure, Tertiary / Q000235:genetics; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D021381:Protein Transport / Q000187:drug effects / Q000235:genetics; D000685:Serum Amyloid A Protein / Q000096:biosynthesis / Q000235:genetics; D015238:Sulfotransferases / Q000235:genetics / Q000378:metabolism*
D053829:Amyloid Precursor Protein Secretases; D020126:Brefeldin A; D006497:Heparan Sulfate; D006603:Hexuronic Acids; D007476:Ionophores; D008985:Monensin; D009842:Oligopeptides; D021382:Protein Sorting Signals; D011500:Protein Synthesis Inhibitors; D000685:Serum Amyloid A Protein; D015238:Sulfotransferases; C495708:N-benzyloxycarbonyl-valyl-leucyl-leucinal; C485756:Hs6st1 protein, mouse; C485759:Hs6st3 protein, mouse